{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:01:19Z","timestamp":1791860479233,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jbo.2026.100761","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:54:50Z","timestamp":1775667290000},"page":"100761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["MiRNA-based expression signatures in differential diagnosis of enchondroma and chondrosarcoma"],"prefix":"10.1016","volume":"58","author":[{"given":"Annabell","family":"Walter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Katenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Ga\u00dfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Weschenfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunther O.","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Malouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Rinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H.","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2131-6779","authenticated-orcid":false,"given":"Karin G.","family":"Schrenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2026.100761_b0005","unstructured":"Institute, N. C. SEER cancer statistics: Bone and Joint Cancer Statistics, (2024)."},{"key":"10.1016\/j.jbo.2026.100761_b0010","first-page":"1127","article-title":"Bone cancer incidence by morphological subtype: a global assessment","volume":"26","author":"Valery","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jbo.2026.100761_b0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ijc.34694","article-title":"Twenty-year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors","volume":"154","author":"Xu","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbo.2026.100761_b0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V","article-title":"Bone cancers","volume":"75","author":"Dorfman","year":"1995","journal-title":"Cancer"},{"issue":"2014","key":"10.1016\/j.jbo.2026.100761_b0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.semdp.2014.01.006","article-title":"Cartilage-forming tumors","volume":"31","author":"Qasem","year":"2014","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.jbo.2026.100761_b0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1054\/cdip.2001.0082","article-title":"Cartilage-forming tumours of bone and soft tissue and their differential diagnosis","volume":"7","author":"Bovee","year":"2001","journal-title":"Curr. Diagn. Pathol."},{"key":"10.1016\/j.jbo.2026.100761_b0035","first-page":"94","article-title":"Soft tissue sarcomas","volume":"54","author":"Cormier","year":"2004","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbo.2026.100761_b0040","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4065\/82.11.1409","article-title":"Sarcoma","volume":"82","author":"Skubitz","year":"2007","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jbo.2026.100761_b0045","article-title":"The epidemiology of sarcoma","volume":"14","author":"Burningham","year":"2012","journal-title":"Clin. Sarcoma Res. 2"},{"key":"10.1016\/j.jbo.2026.100761_b0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2000-6855","article-title":"Enchondroma and chondrosarcoma","volume":"4","author":"Flemming","year":"2000","journal-title":"Semin. Musculoskelet. Radiol."},{"key":"10.1016\/j.jbo.2026.100761_b0055","doi-asserted-by":"crossref","unstructured":"W.A. Chow, Chondrosarcoma: biology, genetics, and epigenetics, F1000Res 7 (2018), https:\/\/doi.org\/10.12688\/f1000research.15953.","DOI":"10.12688\/f1000research.15953.1"},{"key":"10.1016\/j.jbo.2026.100761_b0060","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B","article-title":"Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading","volume":"40","author":"Evans","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2026.100761_b0065","article-title":"Classification of chondrosarcoma: from characteristic to challenging imaging findings","volume":"15","author":"Kim","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbo.2026.100761_b0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.5435\/JAAOS-D-20-01188","article-title":"Chondrosarcom","volume":"29","author":"Weinschenk","year":"2021","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"10.1016\/j.jbo.2026.100761_b0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5858\/arpa.2019-0441-RA","article-title":"Differential diagnosis of cartilaginous lesions of bone","volume":"144","author":"Suster","year":"2020","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jbo.2026.100761_b0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/PAS.0b013e31817eec2b","article-title":"Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors","volume":"33","author":"Eefting","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jbo.2026.100761_b0085","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00330-017-4947-0","article-title":"What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas?","volume":"28","author":"Douis","year":"2018","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jbo.2026.100761_b0090","doi-asserted-by":"crossref","unstructured":"H. Douis, A. Saifuddin,The imaging of cartilaginous bone tumours. I. Benign lesions.Skeletal Radiol, 41(10) (2012) 1195-212, https:\/\/doi.org\/10.1007\/s00256-012-1427-0.","DOI":"10.1007\/s00256-012-1427-0"},{"issue":"5","key":"10.1016\/j.jbo.2026.100761_b0095","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00256-012-1521-3","volume":"42","author":"Douis","year":"2013","journal-title":"Skeletal Radiol."},{"issue":"5","key":"10.1016\/j.jbo.2026.100761_b0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1148\/rg.235035134","article-title":"From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation","volume":"23","author":"Murphey","year":"2003","journal-title":"Radiographics"},{"key":"10.1016\/j.jbo.2026.100761_b0105","doi-asserted-by":"crossref","unstructured":"A.M. Davies, A. Patel, C. Azzopardi, S.l. James & R. Botchu, Birmingham atypical cartilaginous tumour imaging protocol (BACTIP) revisited, Clin Radiol 83 (2025) 106837, https:\/\/doi.org\/10.1016\/j.crad.2025.106837.","DOI":"10.1016\/j.crad.2025.106837"},{"key":"10.1016\/j.jbo.2026.100761_b0110","doi-asserted-by":"crossref","unstructured":"A. Patel, A.M. Davies, R. Botchu and S.A., A pragmatic approach to the imaging and follow-up of solitary central cartilage tumours of the proximal humerus and knee, Clin Radiol 74(7) (2019) 517-526, https:\/\/doi.org\/10.1016\/j.crad.2019.01.025.","DOI":"10.1016\/j.crad.2019.01.025"},{"key":"10.1016\/j.jbo.2026.100761_b0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/jclinpath-2018-205071","article-title":"Biomarkers of chondrosarcoma","volume":"71","author":"Jeong","year":"2018","journal-title":"J. Clin. Pathol."},{"issue":"2021","key":"10.1016\/j.jbo.2026.100761_b0120","first-page":"119","article-title":"The WHO classification of tumors of bone: an updated review","volume":"28","author":"Choi","year":"2020","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.jbo.2026.100761_b0125","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/path.2913","article-title":"IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours","volume":"224","author":"Amary","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.jbo.2026.100761_b0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00428-014-1685-4","article-title":"Isocitrate dehydrogenase 1 mutations (IDH1) and p16\/CDKN2A copy number change in conventional chondrosarcomas","volume":"466","author":"Amary","year":"2015","journal-title":"Virchows Arch."},{"issue":"6","key":"10.1016\/j.jbo.2026.100761_b0135","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.3390\/ijms25063176","article-title":"MicroRNAs as prognostic biomarkers and therapeutic targets in chondrosarcoma","volume":"25","author":"Skipar","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbo.2026.100761_b0140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol (lausanne)"},{"key":"10.1016\/j.jbo.2026.100761_b0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jbo.2026.100761_b0150","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jbo.2026.100761_b0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jbo.2026.100761_b0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jbo.2026.100761_b0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.1215691","article-title":"miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay","volume":"336","author":"Djuranovic","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jbo.2026.100761_b0170","doi-asserted-by":"crossref","unstructured":"C.E. Condrat et al., miRNAs as Biomarkers in Disease: Latest Findings Regarding their Role in Diagnosis and Prognosis Cells 9 (2020), https:\/\/doi.org\/10.3390\/cells9020276.","DOI":"10.3390\/cells9020276"},{"key":"10.1016\/j.jbo.2026.100761_b0175","doi-asserted-by":"crossref","unstructured":"L. Zhang et al., Use of MicroRNA biomarkers to distinguish enchondroma from low-grade chondrosarcoma, Connect Tissue Res 58 (2017) 155-161, https:\/\/doi.org\/10.1080\/03008207.2016.1197212.","DOI":"10.1080\/03008207.2016.1197212"},{"key":"10.1016\/j.jbo.2026.100761_b0180","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/jbmr.3976","article-title":"The miR-143\/145 cluster, a novel diagnostic biomarker in chondrosarcoma, acts as a tumor suppressor and directly inhibits fascin-1","volume":"35","author":"Urdinez","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbo.2026.100761_b0185","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jbo.2026.100761_b0190","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.mpdhp.2022.09.001","article-title":"Benign and low-grade cartilaginous tumors: an update on differential diagnosis","volume":"28","author":"Savci-Heijink","year":"2022","journal-title":"Diagn. Histopathol."},{"key":"10.1016\/j.jbo.2026.100761_b0195","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41467-017-01027-z","article-title":"Comprehensive analysis of normal adjacent to tumor transcriptomes","volume":"8","author":"Aran","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbo.2026.100761_b0200","first-page":"398","article-title":"Derepression of MicroRNA-138 contributes to loss of the human articular chondrocyte phenotype, arthritis","volume":"68","author":"Seidl","year":"2016","journal-title":"Rheumatol"},{"key":"10.1016\/j.jbo.2026.100761_b0205","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1158\/1541-7786.MCR-14-0697","article-title":"miR-181a targets RGS16 to promote chondrosarcoma growth, angiogenesis, and metastasis","volume":"13","author":"Sun","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbo.2026.100761_b0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12935-015-0247-4","article-title":"Implications of miR cluster 143\/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis","volume":"15","author":"Das","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jbo.2026.100761_b0215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9440(10)63799-6","article-title":"Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro","volume":"162","author":"Jawhari","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jbo.2026.100761_b0220","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1158\/0008-5472.CAN-07-0929","article-title":"Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer","volume":"67","author":"Vignjevic","year":"2007","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.jbo.2026.100761_b0225","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood.2019003978","article-title":"Platelets and tumor-associated RNA transfer","volume":"137","author":"D\u2019Ambrosi","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jbo.2026.100761_b0230","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.jbo.2026.100761_b0235","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2013-03-492801","article-title":"Activated platelets can deliver mRNA regulatory Ago2 microRNA complexes to endothelial cells via microparticles","volume":"122","author":"Laffont","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jbo.2026.100761_b0240","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCRESAHA.110.226456","article-title":"Microparticles: protagonists of a novel communication network for intercellular information exchange","volume":"107","author":"Mause","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbo.2026.100761_b0245","doi-asserted-by":"crossref","unstructured":"K. Brinkman et al., Extracellular vesicles from plasma have higher tumour RNA fraction than platelets, J Extracell Vesicles 9(1) (2020) 1741176, https:\/\/doi.org\/10.1080\/20013078.2020.1741176.","DOI":"10.1080\/20013078.2020.1741176"},{"issue":"10","key":"10.1016\/j.jbo.2026.100761_b0250","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.7150\/thno.40532","article-title":"Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137426000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137426000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:36:37Z","timestamp":1780976197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137426000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"alternative-id":["S2212137426000230"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2026.100761","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiRNA-based expression signatures in differential diagnosis of enchondroma and chondrosarcoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2026.100761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100761"}}